Connecticut gubernatorial hopeful Tom Foley is already airing campaign ads on TV — but not in his home state.
The 2010 Republican nominee, who is exploring another bid for the state’s top office, launched the first TV spot of the 2014 Nutmeg State race on Monday. The ad, which is running only on cable in New York City, invites city residents wary of Mayor-elect Bill de Blasio’s progressive policies to consider moving to Connecticut next year when the state “will probably elect a new governor.”
The spot opens with an image of a recent New York Post cover that put de Blasio’s face next to a Soviet hammer and sickle. “Hey, New York City,” Foley says while talking directly to the camera. “With your new mayor, I know many of you are thinking about leaving. Connecticut, with the same progressive policies you’re about to see in your city, may not be first on your mind. But wait a second. Connecticut next year will probably elect a new governor. When it does, Connecticut once again will be the place that people want to be in the Northeast.”
The “small” ad buy was scheduled to begin Monday on Fox News Channel and NY1 in New York City, according to the Hartford Courant. The unusual tactic of running the ad out of state speaks to what is probably Foley’s true aim: Generating a lot of attention and raising money as a result.
So far, it has worked, at least in the attention department: Foley’s ad generated coverage late Monday in outlets throughout Connecticut and New York. Asked Tuesday if he was concerned the strategy might backfire, Foley laughed and simply said, “No.”
Foley lost to Democratic Gov. Dannel Malloy by just 1 percentage point in 2010, and Republicans are hopeful that Malloy’s mediocre polling numbers give them a solid chance to knock him off next year. But Foley faces a crowded GOP primary field, with state Senate Minority Leader John McKinney, state Sen. Toni Boucher, and Danbury Mayor Mark Boughton, who was Foley’s running mate in 2010, all readying campaigns of their own.
- 1 The Story of 2016: Republicans Feeling “Betrayed” by Their Leaders
- 2 The 14 House Primaries to Watch Tuesday
- 3 After Trump, GOP Foreign Policy Faces an Uncertain Future
- 4 Climate Stances Put Pressure on Major Trade Groups
- 5 Smart Ideas: Oil Pipelines vs. Oil Trains, and the Next Generation of Biological Threats
What We're Following See More »
Sigmar Gabriel, the German economic minister, said there's no chance of the Transatlantic Trade and Investment Partnership being agreed upon before the U.S. elections this fall. Gabriel said the United States "had effectively ended talks" on the free trade deal with the European Union "because Washington had not wanted to compromise with its European counterparts."
In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.
“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”
"Humanity’s impact on the Earth is now so profound that a new geological epoch—the Anthropocene—needs to be declared," according to a panel of scientists. "The new epoch should begin about 1950, the experts said, and was likely to be defined by the radioactive elements dispersed across the planet by nuclear bomb tests, although an array of other signals, including plastic pollution, soot from power stations, concrete, and even the bones left by the global proliferation of the domestic chicken."
The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.